BAXTER INTERNATIONAL INC. Business Combination, Acquisition Related Costs
BAXTER INTERNATIONAL INC. (BAX) reported Business Combination, Acquisition Related Costs of $14.00 million for the 3-month period ending 2013-09-30, per its 10-Q filed 2013-10-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessCombinationAcquisitionRelatedCosts · last filed 2013-10-30
- BAXTER INTERNATIONAL INC. business combination, acquisition related costs for the quarter ending 2013-09-30 was $14.00M.
| Period end | Business Combination, Acquisition Related Costs 3 month |
|---|---|
| 2013-09-30 | $14.00M 10-Q · filed 2013-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |